Skip to content

NADIMED

Active Private limited companyfounded 2003active for 23 yearsPrins Boudewijnlaan 7b, 2550 KontichKBO/BCE: BE 0859.727.529 subsidiary of

Lifetime

22 annual accounts with figures on one time axis
peak of €2.1m in 2022
-not published
peak of €1.4m in 2022
€112,140▼ 81.5%
peak of €5.2m in 2022
€821,966▼ 32.9%
€1.5m▼ 24.7%
peak of 4.3 FTE in 2026
4.3 FTE▲ 38.7%
Board2 names since 2024
- 
Owners2 names in the annual accounts
100% and 1 other
Documentsfilings and deeds
15-09-202646 days before the deadline
2026financial year
Result from €607,597 to €112,140Staff from 3.1 FTE to 4.3 FTE1 director appointed, 1 resignation, 1 statutory auditor reap… 22-10. resigns as director 23-02Dividend €500,000Equity from €1.2m to €821,966

Key points

from the 2026 annual accounts

Equity

€821,966 from €5.2m in 2022

Equity fell by 84% in 4 years.

Result

€112,140 ▼ 81.5%
€608,0002025€112,0002026

The result fell in 2026 from €607,597 to €112,140.

Staff

4 employees on 31-03-2026
112022012024302025012026

In 2026, nobody joined and 1 employee left. On top of that, 0.2 agency workers worked there on average.

Board

1 joined · 1 left

1 director joined and 1 left, the latest change on 22-10-2026. 1 is in office now.

Position in the sector

€821,966

Less equity than 85% of companies in wholesale trade. The sector median is €7.0m, over 227 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 17,048 companies had the same profile as NADIMED has now. Each dot stands for 43 companies, two years later.

94.3%
were still trading
5.0%
stopped another way
0.6%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 17,048 companies, not a prediction for NADIMED. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Auditor,
  • 100%score equity €5.2m (2026) · annual accounts 31-03-2026
  • consolidatesannual accounts 31-03-2026
Board & ownership

Recent changes

1 director appointed, 1 resignation, 1 statutory auditor reappointed reappointed as statutory auditor · resigns · appointed · General meeting of 17-09-2026 · Gazette deed
. resigns as director acts as permanent representative · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0859727529
appointed as statutory auditor acts as permanent representative · Gazette deed
All 49 events

Comparable companies

same main activity, similar in size and age
Company
NADIMED Kontich €13.0m 1.1% 36.2% 4.3
LABO'LIFE BELGIUM Namur €9.9m 1.6% 44.9% 9.7
ALEAMED Kontich €15.9m 0.5% 4.4% 9.8
VETRINORD Wuustwezel €13.0m 3.1% 71.6% 4.5
REVIMEX Pelt €7.1m 7.3% 44.9% 6.1
VETRIA Beernem €16.1m -1.1% 44.2% 4.7
Benelux Scientific Nazareth-De Pinte €6.0m 2.2% 26.8% 7.6
-10%0%10%20%€10m€100m€1bn€10bnNADIMEDEBIT margin

Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.

These companies have the same main activity as NADIMED: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €2.2m and €7.8m, founded between 1989 and 2005.

Official details

Source: KBO
Status
Active since 23-07-2003Normal situation
Registered office
30 active companies are registered at this addressSource: KBO register, as of 21 November 2026.
Activity
Wholesale of pharmaceutical and medical goodsNACE 46460
Joint committee
200Auxiliary committee for white-collar workers · annual accounts 31-03-2026
Establishment unit
2.314.684.5712550 Kontich, since 01-06-2020
Financial year end
31 March
Peppol
Reachable since 09-05-2025
Company details

Annual accounts to 31-03-2026

€2.3m▼ 27.9%
Employeeson 31-03-2026
4▼ 20.0%
Filing
Filed on 15-09-2026, 46 days before the end of the filing period
Financials

Insights on NADIMED

NADIMED has existed since 2003. In 2007 the gross margin rose from €68,595 to €176,593.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about NADIMED

What is the company number of NADIMED?
The company number of NADIMED is 0859.727.529. The VAT number is the same number with BE in front: BE 0859.727.529.
Where is NADIMED based?
The registered office is at Prins Boudewijnlaan 7b, 2550 Kontich.Company details
What does NADIMED do?
According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
What is the legal form of NADIMED?
NADIMED is a private limited company (BV).
When was NADIMED founded?
NADIMED was founded on 23-07-2003.
Is NADIMED still active?
Yes, NADIMED is an active enterprise in the KBO register.
How many employees does NADIMED have?
NADIMED had an average of 4.3 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
Which joint committee does NADIMED fall under?
In its 31-03-2026 annual accounts, NADIMED states joint committee 200 (Auxiliary committee for white-collar workers).
What is the turnover of NADIMED?
The turnover of NADIMED was €13.0m in financial year 2026, according to the filed annual accounts.
Is NADIMED profitable?
In financial year 2026, NADIMED made a profit of €112,140.
Where can I find the annual accounts of NADIMED?
NADIMED filed 22 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
When are the next annual accounts of NADIMED due?
NADIMED must file the annual accounts for financial year 2027 by 31-10-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.